AI
Microsoft Unveils Project Quine for Biological Research
Microsoft has introduced Project Quine, an AI system designed to accelerate drug discovery by bridging computational modeling and laboratory research.
September 30, 2026, 09:02 AM·IT之家
#drug-discovery
AI
Microsoft Unveils Quine AI to Accelerate Biological Research
Microsoft has introduced Quine, an AI research system designed to model biological complexity and accelerate drug discovery by reducing research cycles from months to days.
cnBeta.COM
AI
Qiagen Integrates Curated Data into AI Drug Discovery Agents
Qiagen is enhancing drug discovery AI agents by grounding them in a 25-year-old curated knowledge base to ensure data accuracy and traceability.
SiliconANGLE
AI
Anthropic Expands AI Capabilities Into Physical Wet Labs
Anthropic has opened a wet lab in the San Francisco Bay Area to enable AI-driven physical experiments in drug discovery and life sciences.
cnBeta.COM
AI
Anthropic Launches Biotech Lab to Advance AI-Driven Drug Discovery
Anthropic has established a new laboratory in the San Francisco Bay Area to advance drug discovery by integrating its AI agents with robotic laboratory automation.
3DNews - Daily Digital Digest
AI
Anthropic Integrates Wet Labs Into AI Drug Discovery Pipeline
Anthropic is expanding its AI drug discovery efforts by opening physical biology labs and hiring scientists to validate molecular hypotheses generated by the Claude model.
Crypto Briefing
Money
Magnitude Biosciences Raises €1.5 Million for Drug Discovery Platform
UK-based Magnitude Biosciences secured €1.5 million to scale its in-vivo drug discovery platform, triggering an additional €253,000 grant from Innovate UK.
EU-Startups
AI
AI-Designed Drug Shows Potential to Slow Biological Aging
Insilico Medicine's AI-generated drug Rentosertib showed a decrease in biological age markers for 43 patients in a clinical trial.
IT之家
AI
AI-Generated Drug Shows Potential to Reverse Biological Age
Insilico Medicine's AI-designed drug rentosertib showed signs of reversing biological aging markers in a trial with 42 patients.
The Decoder
That is everything